OMA Guidelines Bundle

Obesity-Related Diseases 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544298

Contents of this Issue

Navigation

Page 12 of 45

13 (cont'd) Effects of Adiposopathy on CKM and Other Systems (cont'd) System Key Concepts Musculoskeletal • Osteoarthritis • Slipped capital femoral epiphysis (SCFE) • Blount disease • Degenerative joint disease • Increased biomechanical forces exert pressure on multiple joints and bones. • Chronic low-grade inflammation and tissue hypoxia with fibrosis can lead to reduced connective tissue strength and impaired tissue repair. • Pain is accentuated with disrupted neurohormonal signaling. • In children, the femoral growth plate is affected causing SCFE and increased mechanical stress on the proximal tibial physis causing Blount's Disease Pulmonary • Obstructive sleep apnea (OSA) • Obesity hypoventilation syndrome (OHS) • Asthma • Increased fat deposition in the upper airways contributes to OSA. • Increased fat deposition in the chest wall impairs lung compliance and functional residual capacity, leading to OHS. • Chronic low-grade inflammation can contribute to inflammation of the lower airways. Oncologic • Breast • Ovarian • Endometrial • Esophageal • Gastric • Pancreatic • Colon • Chronic low-grade inflammation contributes to tumorigenesis and angiogenesis. • Excess circulating insulin and other obesity-related growth factors promotes abnormal cellular growth. Neurologic/ ophthalmologic • Migraines • Idiopathic intracranial hypertension • Chronic low-grade inflammation and disrupted pain signaling play a role in migraine headaches. • Chronic low-grade inflammation increases cerebrospinal fluid (CSF) production. • Increased intraabdominal and intrathoracic pressures also contribute to intracranial hypertension.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases 2026